AbbVie, Inc. (ABBV)
264.49
-0.47
(-0.18%)
USD |
NYSE |
Aug 24, 16:00
264.58
+0.09
(+0.03%)
After-Hours: 19:58
AbbVie Debt to Equity Ratio : -11.93 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -11.93 |
| March 31, 2026 | -10.95 |
| December 31, 2025 | -20.85 |
| September 30, 2025 | -26.02 |
| June 30, 2025 | -385.14 |
| March 31, 2025 | 49.22 |
| December 31, 2024 | 20.40 |
| September 30, 2024 | 11.78 |
| June 30, 2024 | 10.42 |
| March 31, 2024 | 9.242 |
| December 31, 2023 | 5.803 |
| September 30, 2023 | 5.023 |
| June 30, 2023 | 4.742 |
| March 31, 2023 | 4.678 |
| December 31, 2022 | 3.720 |
| September 30, 2022 | 4.352 |
| June 30, 2022 | 4.977 |
| March 31, 2022 | 4.512 |
| December 31, 2021 | 5.035 |
| September 30, 2021 | 5.957 |
| June 30, 2021 | 6.535 |
| March 31, 2021 | 6.238 |
| December 31, 2020 | 6.658 |
| September 30, 2020 | 5.701 |
| June 30, 2020 | 5.944 |
| Date | Value |
|---|---|
| March 31, 2020 | -9.042 |
| December 31, 2019 | -8.210 |
| September 30, 2019 | -4.714 |
| June 30, 2019 | -4.397 |
| March 31, 2019 | -4.800 |
| December 31, 2018 | -4.773 |
| September 30, 2018 | -13.87 |
| June 30, 2018 | -11.00 |
| March 31, 2018 | 10.49 |
| December 31, 2017 | 7.331 |
| September 30, 2017 | 5.652 |
| June 30, 2017 | 6.197 |
| March 31, 2017 | 7.393 |
| December 31, 2016 | 7.947 |
| September 30, 2016 | 5.768 |
| June 30, 2016 | 6.710 |
| March 31, 2016 | 6.873 |
| December 31, 2015 | 8.028 |
| September 30, 2015 | 6.606 |
| June 30, 2015 | 5.655 |
| March 31, 2015 | 11.09 |
| December 31, 2014 | 8.617 |
| September 30, 2014 | 3.184 |
| June 30, 2014 | 2.825 |
| March 31, 2014 | 3.067 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Biogen, Inc. | 0.4433 |
| Gilead Sciences, Inc. | 2.219 |
| Regeneron Pharmaceuticals, Inc. | 0.0854 |
| Amgen, Inc. | 4.903 |
| REGENXBIO, Inc. | 3.49 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 135.12B |
| Total Liabilities (Quarterly) | 141.00B |
| Shareholders Equity (Quarterly) | -5.935B |
| Current Ratio | 0.8085 |
| Net Debt Paydown Yield | -0.04% |